Xiaoran Zhang Selected Research

Xiaoran Zhang Research Topics

Disease

26	Neoplasms (Cancer) 05/2024 - 11/2013
10	Glioma (Gliomas) 04/2024 - 10/2016
7	Inflammation (Inflammations) 02/2023 - 01/2016
6	COVID-19 03/2024 - 01/2021
4	Colitis 12/2023 - 11/2016
3	Brain Neoplasms (Brain Tumor) 05/2024 - 01/2022
3	Glioblastoma (Glioblastoma Multiforme) 01/2023 - 01/2021
3	Type 2 Diabetes Mellitus (MODY) 01/2023 - 05/2020
3	Contact Dermatitis (Eczema, Contact) 06/2022 - 01/2017
2	Critical Illness (Critically Ill) 01/2024 - 12/2015
2	Body Weight (Weight, Body) 01/2023 - 01/2021
2	Hyperglycemia 01/2023 - 01/2023
2	Wounds and Injuries (Trauma) 01/2022 - 06/2015
2	Memory Disorders (Memory Loss) 01/2022 - 01/2021
2	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 02/2015
2	Infections 01/2021 - 01/2011
2	Fibrosis (Cirrhosis) 05/2020 - 03/2019
2	Non-alcoholic Fatty Liver Disease 05/2020 - 01/2017
2	Necrosis 08/2019 - 01/2011
2	Hyperalgesia 03/2019 - 11/2013
2	Hematoma 12/2015 - 06/2015
1	Neoplasm Metastasis (Metastasis) 05/2024
1	Ganglion Cysts (Ganglion) 04/2024
1	Osteoporosis 01/2024
1	Thrombosis (Thrombus) 01/2024
1	Venous Thromboembolism 01/2024
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2023
1	Carcinoma (Carcinomatosis) 11/2023
1	Starvation 10/2023
1	Poisoning 08/2023
1	Pain (Aches) 07/2023
1	Humeral Fractures 03/2023
1	Thrombotic Thrombocytopenic Purpura 02/2023
1	Ganglioneuroma 01/2023
1	Pancreatitis 01/2023

Drug/Important Bio-Agent (IBA)

4	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 04/2024 - 01/2022
4	Therapeutic UsesIBA 12/2023 - 01/2018
4	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2019
3	Biomarkers (Surrogate Marker)IBA 11/2023 - 05/2020
3	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2022
3	LipidsIBA 01/2023 - 01/2017
3	LigandsIBA 01/2022 - 10/2016
3	Vitamin D FDA LinkGeneric 08/2020 - 10/2009
2	SteroidsIBA 05/2024 - 01/2024
2	AcidsIBA 04/2024 - 01/2022
2	fibrin fragment D (D-dimer)IBA 01/2024 - 02/2023
2	RNA (Ribonucleic Acid)IBA 11/2023 - 01/2022
2	Insulin (Novolin)FDA Link 01/2023 - 01/2023
2	InterleukinsIBA 12/2022 - 08/2019
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 01/2018
2	Decitabine FDA Link 01/2022 - 10/2016
2	Amyloid (Amyloid Fibrils)IBA 01/2022 - 01/2021
2	EnzymesIBA 01/2021 - 01/2016
2	CytokinesIBA 08/2019 - 01/2018
2	Vincristine (Oncovin)FDA LinkGeneric 03/2019 - 11/2013
2	Serotonin (5 Hydroxytryptamine)IBA 03/2019 - 11/2013
2	auraptenolIBA 03/2019 - 11/2013
2	Messenger RNA (mRNA)IBA 01/2019 - 12/2016
2	Trinitrobenzenesulfonic AcidIBA 01/2019 - 11/2016
2	ChemokinesIBA 01/2018 - 01/2017
2	Isoflurane FDA LinkGeneric 01/2016 - 01/2016
1	melanopsinIBA 04/2024
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 04/2024
1	Cellular Retinol-Binding ProteinsIBA 04/2024
1	fibrinmonomerIBA 01/2024
1	Antithrombin IIIIBA 01/2024
1	Fibrinogen (Factor I)FDA Link 01/2024
1	von Willebrand FactorIBA 01/2024
1	Interleukin-10 (Interleukin 10)IBA 12/2023
1	Long Noncoding RNAIBA 11/2023
1	Thyroid HormonesIBA 10/2023
1	ChloridesIBA 08/2023
1	Fluorescein (Funduscein)FDA LinkGeneric 06/2023
1	theasinensin AIBA 03/2023
1	Fumigant 93 (D-D)IBA 02/2023
1	BilirubinIBA 02/2023
1	thiamine triphosphorate (TTP)IBA 02/2023
1	Metalloproteases (Metalloproteinases)IBA 02/2023
1	DisintegrinsIBA 02/2023
1	ThrombospondinsIBA 02/2023
1	Interleukin-22 (IL-22)IBA 02/2023
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2023
1	Blood Glucose (Blood Sugar)IBA 01/2023
1	HydrogenIBA 01/2023
1	Superoxide DismutaseIBA 01/2023
1	AntioxidantsIBA 01/2023
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2023
1	EpitopesIBA 01/2023
1	ginsenoside Rg1IBA 01/2023
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2023

Therapy/Procedure

13	Therapeutics 04/2024 - 10/2016
7	Immunotherapy 05/2024 - 01/2022
4	Arthroplasty 03/2023 - 01/2021
3	Radiotherapy 05/2023 - 01/2021
2	Transplantation 01/2019 - 01/2018
1	Ambulatory Surgical Procedures (Outpatient Surgery) 03/2024
1	Operative Time 07/2023
1	Craniotomy 06/2023
1	Laparotomy 01/2023
1	Biological Therapy 01/2023